Race impacts outcome in stage III/IV squamous cell carcinomas of the head and neck after concurrent chemoradiation therapy
Kathleen Settle(University of Maryland, Baltimore), Mohan Suntharalingam(University of Maryland, Baltimore), R. Taylor(University of Oxford), Young Kwok(University of Maryland, Baltimore), Kevin Carter(University of Maryland, Baltimore), Jeffery S. Wolf(University of Maryland, Baltimore), Kevin J. Cullen(University of Maryland, Baltimore), Robert A. Ord(University of Maryland, Baltimore), Ann B. Zimrin(University of Maryland, Baltimore), Scott E. Strome(Northwestern Medicine Lake Forest Hospital)
Cited by 27
Related Papers
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
|Nature Medicine|2002|5.1k
Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer
|New England Journal of Medicine|2007|1.7k
Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target
|Proceedings of the National Academy of Sciences|2004|767
Erratum: Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
|Nature Medicine|2002|548